Work

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study

Year: 2026

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2026.01.041

Authors: Fasiha Kanwal, Camden Lopez, Jing Ning, Michelle Luster, K. Rajender Reddy, Neehar D. Parikh, Amit G. Singal, Jorge A. Marrero, Jagpreet Chhatwal, Ziding Feng, Stephanie Page-Lester, Eugene J. Koay, Hashem B. El-Serag

Institutions: Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Fred Hutch Cancer Center, The University of Texas MD Anderson Cancer Center, University of Pennsylvania, University of Michigan, Michigan Medicine, The University of Texas Southwestern Medical Center, Massachusetts General Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Merck, Gilead Sciences, National Institutes of Health, National Cancer Institute

Awards: A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis, Clinical Validation Center for Hepatocellular Carcinoma, Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes, Risk Stratification for and Early Detection of Liver Cancer, The Early Detection Research Network: Data Management and Coordinating Center, UT Southwestern Liver Cancer SPORE, Texas Medical Center Digestive Diseases Center, Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma, Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC), Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome

OpenAlex ID: W7128433502

FWCI:

Cites: 18

Cited by:

Related to: